CME Group Inc.(CME)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
CME | 97.18 B | 22.65x | 0.80% | 63.44% | $11.93 | 15.80% | 0.15x | 1.92% | $329.16 | $218.31 |
SPGI | 116.50 B | 24.41x | 10.40% | 30.54% | $16.19 | 14.26% | 0.43x | 0.99% | $518.88 | $358.55 |
ICE | 85.66 B | 21.55x | 4.80% | 38.25% | $7.08 | 14.09% | 0.69x | 1.32% | $174.25 | $121.39 |
MCO | 77.87 B | 28.53x | 15.10% | 34.25% | $15.76 | 76.93% | 2.41x | 0.88% | $543.25 | $399.61 |
Peer Valuation & Performance Analysis
Peer group analysis for CME Group Inc. (CME) compared to its primary competitors (including SPGI, ICE, MCO) reveals distinct metrics. CME trades at a valuation discount relative to its competitors, with a P/E ratio of 22.7x versus the peer average of 24.8x (representing a 9% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, CME's revenue growth of 0.8% lags behind the peer average of 10.1%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 63.4% compared to the peer average of 34.3%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• CME ranks #2 in P/E ratio, #4 in revenue growth, and #1 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $269.81 | $272.39 | $267.87 | $270.27 | 1,307,600 | +0.03% |
| 2026-10-06 | $269.43 | $272.39 | $266.81 | $270.18 | 1,373,800 | +0.06% |
| 2026-10-05 | $264.67 | $270.17 | $260.35 | $270.03 | 1,564,800 | +2.62% |
| 2026-10-02 | $265.41 | $265.41 | $260.06 | $263.14 | 1,522,400 | -0.74% |
| 2026-10-01 | $263.93 | $267.82 | $262.60 | $265.10 | 2,279,200 | +1.19% |
| 2026-09-30 | $261.86 | $264.88 | $260.49 | $261.98 | 1,903,300 | -0.47% |
| 2026-09-29 | $263.52 | $266.94 | $262.78 | $263.22 | 1,433,500 | -0.01% |
| 2026-09-28 | $266.09 | $268.20 | $262.51 | $263.24 | 1,335,700 | -0.47% |
| 2026-09-25 | $268.72 | $270.77 | $258.87 | $264.48 | 2,201,500 | -1.65% |
| 2026-09-24 | $270.80 | $271.68 | $268.02 | $268.91 | 1,255,000 | -0.70% |
| 2026-09-23 | $267.51 | $274.17 | $267.39 | $270.80 | 1,369,800 | +1.34% |
| 2026-09-22 | $273.43 | $274.70 | $266.92 | $267.21 | 1,798,900 | -3.02% |
| 2026-09-21 | $276.38 | $277.74 | $273.87 | $275.53 | 1,531,800 | -0.17% |
| 2026-09-18 | $271.89 | $277.49 | $270.98 | $276.01 | 3,348,600 | +1.79% |
| 2026-09-17 | $271.24 | $273.23 | $269.45 | $271.15 | 1,593,800 | -0.48% |
Explore More Analysis for CME
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.